GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

Femur length anomalies tend to decrease with later phenology (greater day of year of adulthood anomaly) regardless of elevation or species’ seasonal timing. by César R. Nufio (11646271)

Normalized synergy increased with greater recurrence and decreased with greater feedback. by Samantha P. Sherrill (11114128)

Receiver entropy decreased with greater recurrence and increased with greater feedback. by Samantha P. Sherrill (11114128)

Mean margin gap. by Mizuki Kakizawa (22574740)

Subjects:

Mean internal space gap. by Mizuki Kakizawa (22574740)

Subjects:

Aut:chrX coverage ratio decreases with greater female fraction of introgressors in simulations. by Elizabeth T. Chevy (16828229)

Intraepithelial microneedle penetration of greater than 30% of the epidermis is required to establish detectable intra-epidermal infection in anogenital tissue. by Hafsa Rana (8201886)

Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Subjects:

Study area in the Greater Yellowstone Ecosystem. by Taza D. Schaming (8911517)

Subjects:

Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Mean, SD and individual values of mechanical power difference for technique transitions when increasing and decreasing resistive force. by Gertjan Ettema (2802448)

IRI group exhibited a significantly greater decrease in proportion of gambles accepted compared to the IRI group in the second block. by Yasuhiro Mochizuki (3308349)

Mean time to extinction, <i>T</i>, is plotted against the initial frequency of the focal species <i>x</i>. by Immanuel Meyer (12306666)

Subjects:

The relationships between the mean time to extinction <i>T</i> and the size of the community, <i>N</i>, in different scenarios. by Immanuel Meyer (12306666)

Subjects:

Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”

Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”

Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”

Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…Then, amyloid burden and neuroinflammation were quantified by western-blot, Enzyme-Linked ImmunoSorbent Assay (ELISA), immunofluorescence, and in vivo micro-Positon Emission Tomography (PET) imaging. Viniferin decreased hippocampal amyloid load and deposits with greater efficiency than resveratrol, and both treatments partially prevented the cognitive decline. …”